Opportunistic enteroviral meningoencephalitis: an unusual treatable complication of rituximab therapy.
Ganjoo
Kristen N
KN
Raman
Raghav
R
Sobel
Raymond A
RA
Pinto
Harlan A
HA
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D004770:Enterovirus / Q000235:genetics; D004769:Enterovirus Infections / Q000139:chemically induced / Q000175:diagnosis* / Q000821:virology; D017809:Fatal Outcome; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008297:Male; D008590:Meningoencephalitis / Q000134:cerebrospinal fluid / Q000139:chemically induced / Q000175:diagnosis*; D009894:Opportunistic Infections / Q000139:chemically induced / Q000175:diagnosis / Q000821:virology; D012367:RNA, Viral / Q000134:cerebrospinal fluid; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D012367:RNA, Viral; D000069283:Rituximab